Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
117M
-
Number of holders
-
208
-
Total 13F shares, excl. options
-
127M
-
Shares change
-
+9.75M
-
Total reported value, excl. options
-
$1.25B
-
Value change
-
+$93.7M
-
Put/Call ratio
-
0.26
-
Number of buys
-
88
-
Number of sells
-
-117
-
Price
-
$9.81
Significant Holders of DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) as of Q1 2023
257 filings reported holding DVAX - DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value as of Q1 2023.
DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) has 208 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 127M shares
.
Largest 10 shareholders include BlackRock Inc. (18.9M shares), FEDERATED HERMES, INC. (12.7M shares), STATE STREET CORP (8.94M shares), VANGUARD GROUP INC (8.45M shares), Deep Track Capital, LP (6.35M shares), Chicago Capital, LLC (5.85M shares), BANK OF AMERICA CORP /DE/ (4.34M shares), Bain Capital Life Sciences Investors, LLC (3.92M shares), Fisher Asset Management, LLC (3.89M shares), and PFM Health Sciences, LP (3.81M shares).
This table shows the top 208 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.